Grants
Grants
- Was among the recipients of a $200,000/year UMCP & UMB - Artificial Intelligence + Medicine for High Impact (AIM-HI) Challenge Award for “Precision Therapy for Neonatal Opioid Withdrawal Syndrome,” effective February 15, 2020.
- Received a five-year, $2.4 million grant from the National Institute of Neurological Disorders and Stroke (NIH NINDS), titled "Serotonin and Pain Modulation," effective June 1, 2019.
- Received a 5 year, mPI R01 grant “Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model,” with Istvan Merchenthaler.
- Received a one-year $250,000 grant from the Infectious Diseases Society of America (IDSA) Foundation for “Infectious Etiology of late onset Alzheimer’s Disease.”
- Dr. Linda Chang (Diagnostic Radiology) and Dr. Calu were awarded a one-year $100,000 grant from the Focused Ultrasound Foundation entitled, “Focused ultrasound for neuromodulation in the treatment of opioid addiction.”
- Sam Bacharach, Graduate Student, Program in Neuroscience, in the laboratory of Donna Calu received a three-year, $38,376 Predoctoral National Research Service Award from the National Institute of Drug Abuse (NIH/NIDA) for "The Role of Cannabinoid Receptor-1 in Modulating Addiction Vulnerability." Joseph Cheer, Professor, was co-sponsor.
- Five-year $1,931,250 (total costs) R01 from the National Institute on Drug Abuse to examine the “Role of basolateral amygdala projections in mediating individual differences in motivation and flexibility.”
- Three-year, $300,000 McKnight Memory and Cognitive Disorders Award for her investigation of “Individual Differences in Attention Signaling in Amygdala Circuits.”
- Two-year $70,000 2016 Young Investigator Grant from The Brain and Behavior Research Fund, for her investigation of the “Role of amygdala projections in the incubation of fear and drug craving.”
- Received a five-year, $2,213,950, competing continuation R01 grant from the National Institute on Drug Abuse (NIDA) for “Endogenous Cannabinoid Control of Reward Substrates.” Start date: 7/1/2021.
- Received a five-year, $1,738,125 grant from the National Institute on Drug Abuse (NIDA/NIH) for “Cannabinoid Receptor Control of a DRN to VTA Pathway and its Role in the Affective States,” effective March 1, 2019. Also within Dr. Cheer's lab, Dan Covey, Assistant Professor, was awarded a $1,051,544 K99/R00 award from the NIDA/NIH for “Neural Circuit Control of Mesolimbic Dopamine and Reward,” effective February 2019.
- Five-year $2,200,000 R01 from the National Institute on Drug Abuse to examine the long-term consequences of Ritalin and marijuana exposure in adolescence.
- Received a five-year, $2,500,000 renewal of his existing R01 grant “Consequences of developmental defects in somatosensory map formation” from the National Institute of Neurological Disorders and Stroke (NINDS/NIH).
- Received a one-year $381,304 supplement to his existing R01 grant, from the National Institute of Neurological Disorders and Stroke (NINDS) for “Thalamocortical circuit defects in developmental brain disorders,” effective September 1, 2019.
- Received a five-year $2,475,313 R01 grant, along with Dr. Elizabeth Powell, from the National Institutes of Neurological Disorders and Stroke (NINDS) for “Thalamocortical circuit defects in developmental brain disorders.” The goal of the project is to define sensory thalamocortical synaptic defects in mouse models of Autism Spectrum Disorders.
Megan E. Fox, Postdoctoral Fellow in the laboratory of Mary Kay Lobo
- Received a two-year K99 $351,584 award from the National Institute on Drug Abuse (NIDA) for "Circuit-Specific Molecular Mechanisms in Fentanyl Use and Relapse," effective April 1, 2020.
- Supplement for NIH grant from the Alzheimer’s Disease Initiative funds The parent grant is titled: Cyto-ProSAAS Chaperone Action in Alzheimer's Disease and Frontotemporal Dementia.
- Five-year $2.6 million (direct costs) grant, along with Dr. Nigel Maidment, Co-PI, (UCLA), effective February 1, 2019, from the National Institute on Aging (NIA) for “ProSAAS-mediated neuroprotective mechanisms in Alzheimer’s and Parkinson’s diseases: The role of secretory chaperones in neurodegeneration.”
- Five-year R01 grant from the National Institute on Drug Abuse (NIDA) entitled “Opioid Peptide Synthesizing Enzymes” for 2.1 million dollars (total costs).
- Two-year, $456,663 grant from NIH and the National Institute on Aging for "The Secretory Chaperone 7B2 as Endogenous Regulator of Amyloid Pathology.”
- Dr. Rianne Campbell, Postdoctoral Fellow in Dr. Mary Kay Lobo's laboratory, received a three-year, $200,946 Postdoctoral Fellowship (F32) award from the National Institute on Drug Abuse (NIDA) for “Investigating the Ventral Pallidum-Ventral Tegmental Area Circuit in Cocaine Relapse."
- Dr. Lobo received a five-year, $1,780,984 competitive renewal of her grant from the National Institute on Drug Abuse (NIDA) for "Cocaine-Induced Mitochondrial Mechanisms and Molecular Mediators in Reward Circuity."
- Cali Calarco, PhD, Postdoctoral Fellow in the laboratory of Mary Kay Lobo, PhD, received a partial year, $44,260, Postdoctoral National Research Service Award from the National Institute of Drug Abuse (NIH/NIDA) to study “The Influence of Peroxisome Proliferator-Activated Receptor Gamma Coactivator - 1 Alpha (PGC-1a) on the Nucleus Accumbens During Cocaine-Self-Administration.” Joseph Cheer, PhD, is co-sponsor.
- Eric Choi, PhD Student in the Graduate Program in Biochemistry & Molecular Biology, currently working in the laboratory of Mary Kay Lobo, PhD, received a three-year, $114,849 F31 Predoctoral National Research Service Award from the National Institute of Drug Abuse (NIH/NIDA) to study “Cell Subtype Transcriptional Role of Nab2 in Cocaine Self Administration."
- U01 grant from NIDA. This large Cooperative Agreement is titled "Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes".
- Five-year $1,617,772 RO1 award from the National Institute on Mental Health (NIMH) for "Cell Subtype Mechanisms Underlying Stress Susceptibility and Resilience," effective April 1, 2020.
- Five-year $2,171,420 grant, effective February 1, 2019, from the National Institute of Drug Abuse for “Ventral pallidum molecular mediators in cocaine addiction.”
- Two-year $60,000 start-up research grant from the US-Israel Binational Science Foundation for “Genetics and physiology of ventral pallidum microcircuits.”
- Tree-year $500,000 grant from the National Science Foundation on "Focused electrical stimulator for targeted neuromodulation.”
- Three-year $250,000IMHRO Janssen Rising Star Translational Research Award for “Stabilizing neuronal architecture for Depression therapeutics.”
- Five-year, $1,918,750 R01 grant from the National Institute of Mental Health (NIMH) for "The Neurocircuitry of Depression: Molecular and Cell Subtype Mechanisms”.
- Five-year, $1,918,750 grant from the National Institute on Drug Abuse (NIDA) for "Cell Subtype Transcriptional Mechanisms in Cocaine Addition.”
- Received a $2,200,000 RF1 grant for the first 3-year portion of a 5-year $3,654,000 competing continuation grant from the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA) for "Mechanistic Studies and Therapeutics for ALS/FTD Linked to UBQLN2 Mutations."
- Received a five-year $1,125,000 (direct costs) grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the project “CRF Neural Circuits of Binge Drinking,” effective, April 12, 2019.
- Received a three-year $736,215 continuation award for a K99 grant from the NIH and the National Institute on Alcohol Abuse and Alcoholism for "The Role of the BNST to VTA Neural Circuit in Binge Alcohol Consumption."
- $1,061,248 K99/R00 Pathway to Independence Grant, effective August 1, 2019, from the National Institute on Drug Abuse (NIDA/NIH) for “Effects of exercise on dopaminergic mechanisms of cocaine relapse.”